APA (7th ed.) Citation

Alafate, W., Li, X., Zuo, J., Zhang, H., Xiang, J., Wu, W., . . . Wang, J. (2020). Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma. CNS Neuroscience & Therapeutics, 26(4), 475. https://doi.org/10.1111/cns.13297

Chicago Style (17th ed.) Citation

Alafate, Wahafu, et al. "Elevation of CXCL1 Indicates Poor Prognosis and Radioresistance by Inducing Mesenchymal Transition in Glioblastoma." CNS Neuroscience & Therapeutics 26, no. 4 (2020): 475. https://doi.org/10.1111/cns.13297.

MLA (9th ed.) Citation

Alafate, Wahafu, et al. "Elevation of CXCL1 Indicates Poor Prognosis and Radioresistance by Inducing Mesenchymal Transition in Glioblastoma." CNS Neuroscience & Therapeutics, vol. 26, no. 4, 2020, p. 475, https://doi.org/10.1111/cns.13297.